Journals / European Journal of Rheumatology / 2018 / Cilt: 5 - Sayı: 2

Upper extremity venous thrombosis associated with primary antiphospholipid syndrome and immunoglobulin M nephropathy in diabetes mellitus type II

Pages
145–146
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although, it is reported inthe literature that primary APS coexists with other glomerulonephritis, we did not detect coexistenceof primary APS and IgM nephropathy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Antiphospholipid syndrome (APS) is a disorder characterized by antiphospholipid antibody positivity,arterial or venous thrombosis, and fetal loss.
📊
Key Findings & Data:In a 45-year-old female patient admitted to our clinic with diabetes mellitus and proteinuria,fundus examination did not reveal diabetic retinopathy but a high anticardiolipin IgM and venousthrombosis in the upper extremity were observed.
💡
Conclusion & Impact:Although, it is reported inthe literature that primary APS coexists with other glomerulonephritis, we did not detect coexistenceof primary APS and IgM nephropathy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Antiphospholipid syndrome (APS) is a disorder characterized by antiphospholipid antibody positivity,arterial or venous thrombosis, and fetal loss. In APS, renal as well as vascular and glomerular involve-ment is observed. Systemic lupus erythematosus and other connective tissue diseases should beexcluded to diagnose primary APS. Immunoglobulin M (IgM) nephropathy is characterized by singleor dominant IgM deposition in glomerular mesangium. It often presents with hematuria and pro-teinuria. In a 45-year-old female patient admitted to our clinic with diabetes mellitus and proteinuria,fundus examination did not reveal diabetic retinopathy but a high anticardiolipin IgM and venousthrombosis in the upper extremity were observed. Renal biopsy revealed IgM nephropathy. The pa-tient was diagnosed with primary APS and IgM nephropathy. Cyclophosphamide and steroid treat-ment was started. Her proteinuria decreased as a result of the treatment. Although, it is reported inthe literature that primary APS coexists with other glomerulonephritis, we did not detect coexistenceof primary APS and IgM nephropathy.

🔖

Cite This Article

CANDAN, F., KAYATAŞ, M., HÜZMELİ, C., KOÇKARA, A. Ş., ALAYGUT, D. (2022). Upper extremity venous thrombosis associated with primary antiphospholipid syndrome and immunoglobulin M nephropathy in diabetes mellitus type II. European Journal of Rheumatology, Cilt: 5 - Sayı: 2, 145–146. https://ajindex.com/articles/511659

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Cervera R, Piette JC, Font J, Khamashta MA, Shoen- feld Y, Camps MT, et al. Antiphospholipid syn- drome: clinical and immunological manifestations and pattern of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46: 1019-27. [CrossRef] Fakhouri F, Noël LH, Zuber J, Beaufils H, Martinez F, Lebon P, et al. The expanding spectrum of renal dis- eases associated with antiphospholipid syndrome. Am J Kidney Dis 2003; 41: 1205-11. [CrossRef] Cohen AH, Border WA, Glassock RJ. Nephrotic syndrome with glomerular mesangial IgM de- posits. Lab Invest 1978; 38: 610-9.
  2. Dede F, Simsek Y, Odabas AR, Ayli D, Kayatas M. Pauci-immuneglomerulonephritis associat- ed with primary antiphospholipid syndrome. Rheumatol Int 2008; 28: 499-501. [CrossRef ] Galtier-Dereure F, Biron C, Vies M, Bourgeois V, Schved JF, Bringer J. Vascular complications of dia- betes mellitus: what role for phospholipid-binding antibodies? Lupus 1998; 7: 469-74. [CrossRef] Tarkun I, Hacihanefioğlu A, Tarkun P, Cetinarslan B, Cantürk Z. Anticardiolipin and anti-beta2 gly- coprotein I antibody concentrations in patients with type 2 diabetes mellitus. Diabetes Res Clin- Pract 2005; 68: 181-7. [CrossRef ] Calvo-Romero JM, Lima-Rodríguez EM. Anticardi- olipin Antibodies in Patients with Type 2 Diabetes Mellitus. Clin Med Res 2009; 7: 93-5. [CrossRef] Hendra TJ, Baguley E, Harris EN, Khamashta MH, Trembath RC, Hughes GR, et al. Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease. Postgrad Med J 1989; 65: 140-3. [CrossRef ] Zwi LJ, Yiu TS, Marshall MR, Lam-Po-Tang MK. Non-diabetic renal diseases in a multi-ethnic New Zealand cohort with type 2 diabetes mel- litus: clinical and histopathological features. Pa- thology 2014; 6: 424-32. [CrossRef ] Byun JM, Lee CH, Lee SR, Moon JY, Lee SH, Lee TW, et al. Renal outcomes and clinical course of nondia- betic renal diseases in patients with type 2 diabetes. Korean J InternMed 2013; 28: 565-72. [CrossRef]